JOTEC GmbH - Product Pipeline Analysis, 2023 Update

Summary


Jotec GmbH (Jotec), a subsidiary of Artivion, Inc, is a medical device company that develops, produces and markets implants for the treatment of vascular disease. Its product portfolio includes endovascular and surgical products. It offers thoracic stent grafts, thoracoabdominal stent grafts, abdominal stent grafts, peripheral stent grafts, e-xtra design engineering and surgical portfolio. The company offers hybrid stent graft system for optimized frozen elephant trunk procedure and next generation hybrid stent graft system for frozen elephant trunk technique. Jotec is headquartered in Hechingen, Baden-Wurttemberg, Germany.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company JOTEC GmbH
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note:Some sections may be missing if data is unavailable for the company


JOTEC GmbH Company Overview
JOTEC GmbH Company Snapshot
JOTEC GmbH Pipeline Products and Ongoing Clinical Trials Overview
JOTEC GmbH – Pipeline Analysis Overview
JOTEC GmbH - Key Facts
JOTEC GmbH - Major Products and Services
JOTEC GmbH Pipeline Products by Development Stage
JOTEC GmbH Ongoing Clinical Trials by Trial Status
JOTEC GmbH Pipeline Products Overview
E-liac Stent Graft System
E-liac Stent Graft System Product Overview
E-liac Stent Graft System Clinical Trial
E-nside TAAA Stent Graft
E-nside TAAA Stent Graft Product Overview
E-nside TAAA Stent Graft Clinical Trial
E-nya Thoracic Stent Graft
E-nya Thoracic Stent Graft Product Overview
E-nya Thoracic Stent Graft Clinical Trial
E-Ventus SX
E-Ventus SX Product Overview
E-Vita Open Neo
E-Vita Open Neo Product Overview
E-Vita Open Neo Clinical Trial
JOTEC GmbH - Key Competitors
JOTEC GmbH - Key Employees
JOTEC GmbH - Locations And Subsidiaries
Head Office
Recent Developments
JOTEC GmbH, Recent Developments
May 30, 2023: ‘Korea Needs to Localize Rare Medical Devices Amid Global Supply Shortage’
Mar 05, 2020: CryoLife secures CE Mark for hybrid stent graft system
Dec 02, 2019: CryoLife receives CE mark for E-nya Thoracic Stent Graft
Dec 02, 2019: CryoLife receives CE mark for E-nside thoraco-abdominal stent graft
Jun 20, 2016: Great attendance at the E-vita OPEN PLUS Experts Meeting
Jul 14, 2015: JOTEC Receives CE mark for E-vita THORACIC 3G Stent Graft System with Triple-P Technology
Nov 12, 2014: JOTEC Receives CE mark for E-tegra Stent Graft System
Feb 10, 2014: JOTEC Receives CE mark for E-ventus BX Peripheral Stent Graft System
Jan 10, 2014: JOTEC Receives CE mark for E-liac Stent Graft System
Dec 18, 2013: Green light for new device to treat complex disease of the main heart artery
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: JOTEC GmbH Pipeline Products and Ongoing Clinical Trials Overview
Table 2: JOTEC GmbH Pipeline Products by Indication
Table 3: JOTEC GmbH, Key Facts
Table 4: JOTEC GmbH, Major Products and Services
Table 5: JOTEC GmbH Number of Pipeline Products by Development Stage
Table 6: JOTEC GmbH Pipeline Products Summary by Development Stage
Table 7: JOTEC GmbH Ongoing Clinical Trials by Trial Status
Table 8: JOTEC GmbH Ongoing Clinical Trials Summary
Table 9: E-liac Stent Graft System - Product Status
Table 10: E-liac Stent Graft System - Product Description
Table 11: E-liac Stent Graft System - Prospective Multicenter Registry to Examine the Real-world Performance of the E-liac Stent Graft System for Treatment of Uni- or Bilateral Aorto-iliac or Iliac Aneurysms
Table 12: E-liac Stent Graft System - Prospective Multicenter Study for the Endovascular Treatment of Iliac Aneurysm with the Branched E-liac Stent Graft
Table 13: E-nside TAAA Stent Graft - Product Status
Table 14: E-nside TAAA Stent Graft - Product Description
Table 15: E-nside TAAA Stent Graft - INNER-B - A Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System
Table 16: E-nside TAAA Stent Graft - INNER-B-APAC - Asian Pacific Post-market Clinical Follow-up Study in Patients with Thoracoabdominal Aortic Aneurysms Treated with E-nside TAAA Multibranch Stent Graft System
Table 17: E-nya Thoracic Stent Graft - Product Status
Table 18: E-nya Thoracic Stent Graft - Product Description
Table 19: E-nya Thoracic Stent Graft - CONFORM-TAA - A Post-market Clinical Follow-up Study in Patients with a Descending Thoracic Aortic Aneurysm or Penetrating Aortic Ulcer (PAU) Treated with the E-nya Thoracic Stent Graft System
Table 20: E-nya Thoracic Stent Graft - CONFORM-TAD- A Post-market Clinical Follow-up Study in Patients with Complicated Acute, Subacute or Chronic Type B Aortic Dissection with Double Lumen Treated with the E-nya Thoracic Stent Graft System
Table 21: E-Ventus SX - Product Status
Table 22: E-Ventus SX - Product Description
Table 23: E-Vita Open Neo - Product Status
Table 24: E-Vita Open Neo - Product Description
Table 25: E-Vita Open Neo - A Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO: NEOS
Table 26: E-Vita Open Neo - NEO - E-vita Open Neo Treatment of Aortic Arch Aneurysms and Dissections
Table 27: E-Vita Open Neo - NEOS-APAC - Asian Pacific Post-market Clinical Follow-up Study in Patients with Acute or Chronic Aortic Dissection or Aortic Aneurysm Treated with E-vita OPEN NEO
Table 28: JOTEC GmbH, Key Employees
Table 29: Glossary
List of Figures
Figure 1: JOTEC GmbH Pipeline Products by Development Stage
Figure 2: JOTEC GmbH Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings